Champions Oncology (CSBR) director Ackerman acquired 114,552 shares at $2.10
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Joel Ackerman (director at Champions Oncology Inc., CSBR) reported that they acquired 114,552 shares at $2.10 on Oct 17, 2023. After these transactions the filing shows 856,997 shares held directly.
- Reporting person
- Ackerman Joel
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Oct 17, 2023 | Exercise or conversion of a derivative (M) | Common Stock | +114,552 | $2.10 | $241K | 856,997 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Oct 17, 2023 | Exercise or conversion of a derivative (M) | Option to purchase Common StockOn 114,552 Common Stock1, 2 | -114,552 | avg $2.10 | $241K | 0 direct |
Holdings before and after
- Common Stock: 742,445 to 856,997 direct
- Option to purchase Common Stock: 100,000 to 0 direct
Footnotes from the filing
- 1. 84,600 options were immediately exercisable upon grant on July 19, 2016 with the remaining options vesting on August 5, 2016 and November 5, 2016.
- 2. The options were immediately exercisable upon grant on July 19, 2016.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Ackerman report in this CSBR Form 4?
Joel Ackerman (director at Champions Oncology Inc., CSBR) reported that they acquired 114,552 shares at $2.10 on Oct 17, 2023. After these transactions the filing shows 856,997 shares held directly.
How many CSBR shares does Ackerman hold after this filing?
The filing shows 856,997 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for CSBR
Earlier insider filings at CSBR
- Jan 4, 2024Mendelson Daniel Newman bought $2,915 worth of shares (500 units at $5.83), increasing direct ownership by 0.27% to 183,681 units (SEC Form 4)
- Dec 26, 2023Mendelson Daniel Newman bought $12,300 worth of shares (2,500 units at $4.92), increasing direct ownership by 1% to 183,181 units (SEC Form 4)
- Dec 21, 2023Mendelson Daniel Newman bought $10,122 worth of shares (2,100 units at $4.82), increasing direct ownership by 1% to 180,681 units (SEC Form 4)
- Dec 20, 2023Mendelson Daniel Newman bought $23,750 worth of shares (5,000 units at $4.75), increasing direct ownership by 3% to 178,581 units (SEC Form 4)
- Nov 7, 2023SEC Form 4 filed by Tobin Scott R
Quantisnow market dataNASDAQ
CSBR
Champions Oncology Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for CSBR
Full CSBR profile on Quantisnow Follow CSBR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time